Radiation-sensitizing effect of low-concentration docetaxel on human esophageal squamous cell carcinoma cell lines

Satoshi Tabuchi, Soji Ozawa, Kazuo Koyanagi, Naoyuki Shigematsu, Atsushi Kubo, Masakazu Ueda, Yuko Kitagawa Kitajima, Masaki Kitajima

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Esophageal squamous cell carcinoma (ESCC) is more sensitive to radiation and chemotherapy than other cancers of the digestive system, and combined modality therapy may represent a promising treatment method. The radiation-sensitizing effect of docetaxel on ESCC cell lines was investigated. A colony formation assay was performed in which ESCC cell lines (TE2, TE3) and A431 were exposed to docetaxel (from 1.0x10 11 to 107 M) for 3 h to determine the concentration of docetaxel that was not able to kill individual cells (i.e., the non-cytocidal concentration). Individual cell lines were then exposed to the non-cytocidal concentration of docetaxel prior to, during, and after irradiation to determine whether the timing of docetaxel administration affected cell survival. In addition, flow-cytometry was performed, and the cell cycle was examined prior to and after docetaxel exposure to assess the mechanism of docetaxel as a radiation sensitizer. Docetaxel exhibited a concentration-dependent cytocidal effect, with a different IC50 for each cell type. Almost no cytocidal effect was observed at the following docetaxel concentrations: A431, ≤1.0x1010 M; TE-2 and TE-3, ≤1.0x109 M. Concurrent treatment with docetaxel and radiation tended to decrease cell survival in all the cell lines compared with docetaxel or radiation alone. Cell survival was lowest when the cells were treated using X-ray irradiation after docetaxel exposure (p<0.05). Flow cytometry revealed that in all three cell lines, docetaxel exposure increased the G2/M cell fraction with a higher increase in the cell line that exhibited the highest radiosensitivity This study demonstrated that the administration of docetaxel at a non-cytocidal concentration prior to radiotherapy produced a synergistic cell-killing effect in SCC cell lines.

Original languageEnglish
Pages (from-to)601-606
Number of pages6
JournalExperimental and Therapeutic Medicine
Volume2
Issue number4
DOIs
Publication statusPublished - 2011 Jul

Fingerprint

docetaxel
Radiation-Sensitizing Agents
Cell Line
Cell Survival
Radiation
Esophageal Squamous Cell Carcinoma
Flow Cytometry
Digestive System Neoplasms

Keywords

  • Docetaxel
  • Esophageal squamous cell carcinoma
  • Radiation-sensitizing effect

ASJC Scopus subject areas

  • Medicine(all)
  • Cancer Research
  • Immunology and Microbiology (miscellaneous)

Cite this

Radiation-sensitizing effect of low-concentration docetaxel on human esophageal squamous cell carcinoma cell lines. / Tabuchi, Satoshi; Ozawa, Soji; Koyanagi, Kazuo; Shigematsu, Naoyuki; Kubo, Atsushi; Ueda, Masakazu; Kitajima, Yuko Kitagawa; Kitajima, Masaki.

In: Experimental and Therapeutic Medicine, Vol. 2, No. 4, 07.2011, p. 601-606.

Research output: Contribution to journalArticle

Tabuchi, Satoshi ; Ozawa, Soji ; Koyanagi, Kazuo ; Shigematsu, Naoyuki ; Kubo, Atsushi ; Ueda, Masakazu ; Kitajima, Yuko Kitagawa ; Kitajima, Masaki. / Radiation-sensitizing effect of low-concentration docetaxel on human esophageal squamous cell carcinoma cell lines. In: Experimental and Therapeutic Medicine. 2011 ; Vol. 2, No. 4. pp. 601-606.
@article{e2bc1beeb23542bfbec6e628737556db,
title = "Radiation-sensitizing effect of low-concentration docetaxel on human esophageal squamous cell carcinoma cell lines",
abstract = "Esophageal squamous cell carcinoma (ESCC) is more sensitive to radiation and chemotherapy than other cancers of the digestive system, and combined modality therapy may represent a promising treatment method. The radiation-sensitizing effect of docetaxel on ESCC cell lines was investigated. A colony formation assay was performed in which ESCC cell lines (TE2, TE3) and A431 were exposed to docetaxel (from 1.0x10 11 to 107 M) for 3 h to determine the concentration of docetaxel that was not able to kill individual cells (i.e., the non-cytocidal concentration). Individual cell lines were then exposed to the non-cytocidal concentration of docetaxel prior to, during, and after irradiation to determine whether the timing of docetaxel administration affected cell survival. In addition, flow-cytometry was performed, and the cell cycle was examined prior to and after docetaxel exposure to assess the mechanism of docetaxel as a radiation sensitizer. Docetaxel exhibited a concentration-dependent cytocidal effect, with a different IC50 for each cell type. Almost no cytocidal effect was observed at the following docetaxel concentrations: A431, ≤1.0x1010 M; TE-2 and TE-3, ≤1.0x109 M. Concurrent treatment with docetaxel and radiation tended to decrease cell survival in all the cell lines compared with docetaxel or radiation alone. Cell survival was lowest when the cells were treated using X-ray irradiation after docetaxel exposure (p<0.05). Flow cytometry revealed that in all three cell lines, docetaxel exposure increased the G2/M cell fraction with a higher increase in the cell line that exhibited the highest radiosensitivity This study demonstrated that the administration of docetaxel at a non-cytocidal concentration prior to radiotherapy produced a synergistic cell-killing effect in SCC cell lines.",
keywords = "Docetaxel, Esophageal squamous cell carcinoma, Radiation-sensitizing effect",
author = "Satoshi Tabuchi and Soji Ozawa and Kazuo Koyanagi and Naoyuki Shigematsu and Atsushi Kubo and Masakazu Ueda and Kitajima, {Yuko Kitagawa} and Masaki Kitajima",
year = "2011",
month = "7",
doi = "10.3892/etm.2011.263",
language = "English",
volume = "2",
pages = "601--606",
journal = "Experimental and Therapeutic Medicine",
issn = "1792-0981",
publisher = "Spandidos Publications",
number = "4",

}

TY - JOUR

T1 - Radiation-sensitizing effect of low-concentration docetaxel on human esophageal squamous cell carcinoma cell lines

AU - Tabuchi, Satoshi

AU - Ozawa, Soji

AU - Koyanagi, Kazuo

AU - Shigematsu, Naoyuki

AU - Kubo, Atsushi

AU - Ueda, Masakazu

AU - Kitajima, Yuko Kitagawa

AU - Kitajima, Masaki

PY - 2011/7

Y1 - 2011/7

N2 - Esophageal squamous cell carcinoma (ESCC) is more sensitive to radiation and chemotherapy than other cancers of the digestive system, and combined modality therapy may represent a promising treatment method. The radiation-sensitizing effect of docetaxel on ESCC cell lines was investigated. A colony formation assay was performed in which ESCC cell lines (TE2, TE3) and A431 were exposed to docetaxel (from 1.0x10 11 to 107 M) for 3 h to determine the concentration of docetaxel that was not able to kill individual cells (i.e., the non-cytocidal concentration). Individual cell lines were then exposed to the non-cytocidal concentration of docetaxel prior to, during, and after irradiation to determine whether the timing of docetaxel administration affected cell survival. In addition, flow-cytometry was performed, and the cell cycle was examined prior to and after docetaxel exposure to assess the mechanism of docetaxel as a radiation sensitizer. Docetaxel exhibited a concentration-dependent cytocidal effect, with a different IC50 for each cell type. Almost no cytocidal effect was observed at the following docetaxel concentrations: A431, ≤1.0x1010 M; TE-2 and TE-3, ≤1.0x109 M. Concurrent treatment with docetaxel and radiation tended to decrease cell survival in all the cell lines compared with docetaxel or radiation alone. Cell survival was lowest when the cells were treated using X-ray irradiation after docetaxel exposure (p<0.05). Flow cytometry revealed that in all three cell lines, docetaxel exposure increased the G2/M cell fraction with a higher increase in the cell line that exhibited the highest radiosensitivity This study demonstrated that the administration of docetaxel at a non-cytocidal concentration prior to radiotherapy produced a synergistic cell-killing effect in SCC cell lines.

AB - Esophageal squamous cell carcinoma (ESCC) is more sensitive to radiation and chemotherapy than other cancers of the digestive system, and combined modality therapy may represent a promising treatment method. The radiation-sensitizing effect of docetaxel on ESCC cell lines was investigated. A colony formation assay was performed in which ESCC cell lines (TE2, TE3) and A431 were exposed to docetaxel (from 1.0x10 11 to 107 M) for 3 h to determine the concentration of docetaxel that was not able to kill individual cells (i.e., the non-cytocidal concentration). Individual cell lines were then exposed to the non-cytocidal concentration of docetaxel prior to, during, and after irradiation to determine whether the timing of docetaxel administration affected cell survival. In addition, flow-cytometry was performed, and the cell cycle was examined prior to and after docetaxel exposure to assess the mechanism of docetaxel as a radiation sensitizer. Docetaxel exhibited a concentration-dependent cytocidal effect, with a different IC50 for each cell type. Almost no cytocidal effect was observed at the following docetaxel concentrations: A431, ≤1.0x1010 M; TE-2 and TE-3, ≤1.0x109 M. Concurrent treatment with docetaxel and radiation tended to decrease cell survival in all the cell lines compared with docetaxel or radiation alone. Cell survival was lowest when the cells were treated using X-ray irradiation after docetaxel exposure (p<0.05). Flow cytometry revealed that in all three cell lines, docetaxel exposure increased the G2/M cell fraction with a higher increase in the cell line that exhibited the highest radiosensitivity This study demonstrated that the administration of docetaxel at a non-cytocidal concentration prior to radiotherapy produced a synergistic cell-killing effect in SCC cell lines.

KW - Docetaxel

KW - Esophageal squamous cell carcinoma

KW - Radiation-sensitizing effect

UR - http://www.scopus.com/inward/record.url?scp=79958042618&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79958042618&partnerID=8YFLogxK

U2 - 10.3892/etm.2011.263

DO - 10.3892/etm.2011.263

M3 - Article

VL - 2

SP - 601

EP - 606

JO - Experimental and Therapeutic Medicine

JF - Experimental and Therapeutic Medicine

SN - 1792-0981

IS - 4

ER -